Zobrazeno 1 - 10
of 16
pro vyhledávání: '"N. I. Shavlovskiy"'
Autor:
O. A. Shavlovskaya, I. V. Sarvilina, O. A. Gromova, M. N. Sharov, I. A. Bokova, Y. S. Prokofieva, N. I. Shavlovskiy
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 14, Iss 4, Pp 87-95 (2022)
The article presents new views on the treatment of pain syndromes in musculoskeletal diseases, in particular in osteoarthritis (OA) of various localizations (gonarthrosis, coxarthrosis). New recommendations (2019–2020) of international societies fo
Externí odkaz:
https://doaj.org/article/48db463716584cfa83d6594c1047afd3
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 14, Iss 2, Pp 91-97 (2022)
The novel coronavirus infection is commonly referred to as COVID-19, sometimes by the name of the causative agent of a respiratory viral infection, as SARS-CoV-2. Frequently, the course of COVID-19 is divided into three main periods: acute COVID-19 (
Externí odkaz:
https://doaj.org/article/f4fb24ef89b54b8f94416ab97af11024
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 13, Iss 6, Pp 117-123 (2021)
More than 500 million people worldwide suffer from osteoarthritis (OA). Neck and low back pain (LBP) is one of the most common reasons for visiting a general practitioner to receive primary medical care in different countries. The prevalence of chron
Externí odkaz:
https://doaj.org/article/0f62e73b33ab405db97b8f070194520d
Publikováno v:
Медицинский совет, Vol 0, Iss 19, Pp 74-80 (2021)
Chronic pain continues to remain one of the urgent problems of modern medicine. From 15 to 25% of the adult population suffers from chronic pain. Medical treatment includes the appointment of non-steroidal anti-inflammatory drugs (NSAIDs) and muscle
Externí odkaz:
https://doaj.org/article/179c517afe43482ab6723deb23ffc9a1
Publikováno v:
Медицинский совет, Vol 0, Iss 19, Pp 209-215 (2021)
The issue nonsteroidal anti-inflammatory drugs (NSAIDs) use safety is associated with a high frequency of adverse events (AEs) from the gastrointestinal tract and cardiovascular risks. Patients with lower back pain (LBP) and osteoarthritis (OA), as a
Externí odkaz:
https://doaj.org/article/51b4b298d4074565b29c3ec9a03c63f3
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 52-59 (2021)
Tolperizone is a central type of muscle relaxant that is widely used in clinical practice for the treatment of patients with acute and chronic nonspecific lower back pain(LBP), inflammatory and degenerative-dystrophic joint diseases, and is used in t
Externí odkaz:
https://doaj.org/article/a751de3371864b7096f193edc7e515c8
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 13, Iss 3, Pp 113-118 (2021)
Osteoarthritis (OA) is the most common joint disease globally, and its incidence increases with age – up to 80–90% in people over 60 years. There is a high comorbidity between OA and cardiovascular diseases (CVD), such as arterial hypertension (A
Externí odkaz:
https://doaj.org/article/8e27352f66d840aca1cfe56bfce6ede6
Publikováno v:
Медицинский совет, Vol 0, Iss 21, Pp 61-68 (2021)
Cerebrovascular diseases (CVD) are one of the main causes of mortality and permanent disability in patients. Chronic brain ischemia (CBI) is a slowly progressive dysfunction of the brain with gradually increasing defects in its functioning, which is
Externí odkaz:
https://doaj.org/article/6dc39b8268914555a36178131457878a
Publikováno v:
Nevrologiâ, Nejropsihiatriâ, Psihosomatika, Vol 13, Iss 3, Pp 113-118 (2021)
Osteoarthritis (OA) is the most common joint disease globally, and its incidence increases with age – up to 80–90% in people over 60 years. There is a high comorbidity between OA and cardiovascular diseases (CVD), such as arterial hypertension (A
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 121(3)
Cognitive impairment (CI) develops not only in structural damage to the central nervous system, but also in encephalopathies of dysmetabolic and deficiency etiology. Recently, special attention is focused on the appearance of CI due to the deficiency